TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs17728338
log Bayes Factor = 0.0500158
Chromosome 5   position 150,478,318  (GRCh37) Explore rs17728338 on Ensembl!
Variant rs17728338 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
L40.9 Psoriasis, unspecified
0.139 0.861 0.000
L40 Psoriasis
0.128 0.872 0.000
L40.5 Arthropathic psoriasis
0.119 0.881 0.000
L40.8 Other psoriasis
0.104 0.896 0.000
L40.0 Psoriasis vulgaris
0.100 0.900 0.000
L40.4 Guttate psoriasis
0.092 0.908 0.000
L40.3 Pustulosis palmaris et plantaris
0.092 0.908 0.000
L40.2 Acrodermatitis continua
0.092 0.908 0.000
L40.1 Generalised pustular psoriasis
0.092 0.908 0.000
L40-L45 Papulosquamous disorders
0.060 0.940 0.000
L43 Lichen planus
0.046 0.954 0.000
L44 Other papulosquamous disorders
0.043 0.957 0.000
L41 Parapsoriasis
0.043 0.957 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.043 0.957 0.000
L42 Pityriasis rosea
0.043 0.957 0.000
L43.8 Other lichen planus
0.034 0.966 0.000
L43.9 Lichen planus, unspecified
0.034 0.966 0.000
L43.3 Subacute (active) lichen planus
0.033 0.967 0.000
L43.2 Lichenoid drug reaction
0.033 0.967 0.000
L43.1 Bullous lichen planus
0.033 0.967 0.000
L43.0 Hypertrophic lichen planus
0.033 0.967 0.000
L41.9 Parapsoriasis, unspecified
0.031 0.969 0.000
L41.8 Other parapsoriasis
0.031 0.969 0.000
L41.5 Retiform parapsoriasis
0.031 0.969 0.000
L41.4 Large plaque parapsoriasis
0.031 0.969 0.000
L41.3 Small plaque parapsoriasis
0.031 0.969 0.000
L41.2 Lymphomatoid papulosis
0.031 0.969 0.000
L41.1 Pityriasis lichenoides chronica
0.031 0.969 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.031 0.969 0.000
L44.9 Papulosquamous disorder, unspecified
0.031 0.969 0.000
L44.8 Other specified papulosquamous disorders
0.031 0.969 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.031 0.969 0.000
L44.3 Lichen ruber moniliformis
0.031 0.969 0.000
L44.2 Lichen striatus
0.031 0.969 0.000
L44.1 Lichen nitidus
0.031 0.969 0.000
L44.0 Pityriasis rubra pilaris
0.031 0.969 0.000
D50.8 Other iron deficiency anaemias
0.028 0.972 0.000
K02.9 Dental caries, unspecified
0.000 0.985 0.015
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.014 0.986 0.000
Y45.1 Salicylates
0.013 0.987 0.000
Y45.0 Opioids and related analgesics
0.013 0.987 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.013 0.987 0.000
Y45.5 4-Aminophenol derivatives
0.012 0.988 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.010 0.990 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.010 0.990 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.010 0.990 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.010 0.990 0.000
Y45.8 Other analgesics and antipyretics
0.010 0.990 0.000
Y45.4 Antirheumatics
0.010 0.990 0.000
Y45.2 Propionic acid derivatives
0.009 0.990 0.000
Y44 Agents primarily affecting blood constituents
0.009 0.991 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.009 0.991 0.000
Y44.2 Anticoagulants
0.008 0.992 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.008 0.992 0.000
Y57 Other and unspecified drugs and medicaments
0.008 0.992 0.000
R07.4 Chest pain, unspecified
0.000 0.992 0.008
F33 Recurrent depressive disorder
0.008 0.992 0.000
F10.0 Acute intoxication
0.008 0.992 0.000
Chapter V Mental and behavioural disorders
0.008 0.992 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.008 0.992 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.008 0.992 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.008 0.992 0.000
F33.9 Recurrent depressive disorder, unspecified
0.008 0.992 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.008 0.992 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.008 0.992 0.000
F30-F39 Mood [affective] disorders
0.008 0.992 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.008 0.992 0.000
Y59 Other and unspecified vaccines and biological substances
0.008 0.992 0.000
Y58 Bacterial vaccines
0.008 0.992 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.008 0.992 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.008 0.992 0.000
Y48 Anaesthetics and therapeutic gases
0.008 0.992 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.008 0.992 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.008 0.992 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.008 0.992 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.007 0.992 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.007 0.992 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.007 0.992 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.007 0.992 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.007 0.992 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.007 0.992 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.007 0.992 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.007 0.992 0.000
Y51.0 Anticholinesterase agents
0.007 0.992 0.000
K02 Dental caries
0.000 0.992 0.008
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.007 0.993 0.000
F33.0 Recurrent depressive disorder, current episode mild
0.007 0.993 0.000
F00 Dementia in Alzheimer's disease
0.007 0.993 0.000
F03 Unspecified dementia
0.007 0.993 0.000
F50 Eating disorders
0.007 0.993 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.007 0.993 0.000
F10.5 Psychotic disorder
0.007 0.993 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.007 0.993 0.000
F05 Delirium, not induced by alcohol and other psychoactive substances
0.007 0.993 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.007 0.993 0.000
Y44.7 Plasma substitutes
0.007 0.993 0.000
Y44.6 Natural blood and blood products
0.007 0.993 0.000
Y44.5 Thrombolytic drugs
0.007 0.993 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.007 0.993 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.007 0.993 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.007 0.993 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.007 0.993 0.000
F10.3 Withdrawal state
0.007 0.993 0.000
Y57.9 Drug or medicament, unspecified
0.007 0.993 0.000
D50 Iron deficiency anaemia
0.007 0.993 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.007 0.993 0.000
Y41.5 Antiviral drugs
0.007 0.993 0.000
Y41.4 Anthelminthics
0.007 0.993 0.000
Y41.3 Other antiprotozoal drugs
0.007 0.993 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.007 0.993 0.000
Y41.1 Antimycobacterial drugs
0.007 0.993 0.000
Y41.0 Sulphonamides
0.007 0.993 0.000
F34 Persistent mood [affective] disorders
0.007 0.993 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.007 0.993 0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
0.007 0.993 0.000
F50.0 Anorexia nervosa
0.006 0.993 0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms
0.006 0.993 0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
0.006 0.993 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.006 0.994 0.000
F80-F89 Disorders of psychological development
0.006 0.994 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.006 0.994 0.000
F11 Mental and behavioural disorders due to use of opioids
0.006 0.994 0.000
F19.1 Harmful use
0.006 0.994 0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
0.006 0.994 0.000
F02 Dementia in other diseases classified elsewhere
0.006 0.994 0.000
F09 Unspecified organic or symptomatic mental disorder
0.006 0.994 0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
0.006 0.994 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.006 0.994 0.000
F60-F69 Disorders of adult personality and behaviour
0.006 0.994 0.000
Y57.8 Other drugs and medicaments
0.006 0.994 0.000
Y57.7 Vitamins, not elsewhere classified
0.006 0.994 0.000
Y57.6 Other diagnostic agents
0.006 0.994 0.000
Y57.5 X-ray contrast media
0.006 0.994 0.000
Y57.4 Pharmaceutical excipients
0.006 0.994 0.000
Y57.3 Alcohol deterrents
0.006 0.994 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.006 0.994 0.000
Y57.1 Lipotropic drugs
0.006 0.994 0.000
Y57.0 Appetite depressants [anorectics]
0.006 0.994 0.000
F01 Vascular dementia
0.006 0.994 0.000
F33.8 Other recurrent depressive disorders
0.006 0.994 0.000
F33.4 Recurrent depressive disorder, currently in remission
0.006 0.994 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.006 0.994 0.000
F70-F79 Mental retardation
0.006 0.994 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.006 0.994 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.006 0.994 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.006 0.994 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.006 0.994 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.006 0.994 0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.006 0.994 0.000
F50.9 Eating disorder, unspecified
0.006 0.994 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.994 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.006 0.994 0.000
Y53.7 Emetics
0.006 0.994 0.000
Y53.6 Antidiarrhoeal drugs
0.006 0.994 0.000
Y53.5 Digestants
0.006 0.994 0.000
Y53.4 Other laxatives
0.006 0.994 0.000
Y53.3 Saline and osmotic laxatives
0.006 0.994 0.000
Y53.2 Stimulant laxatives
0.006 0.994 0.000
Y53.0 Histamine H2-receptor antagonists
0.006 0.994 0.000
F99-F99 Unspecified mental disorder
0.006 0.994 0.000
F34.1 Dysthymia
0.006 0.994 0.000
Y56.9 Topical agent, unspecified
0.006 0.994 0.000
Y56.8 Other topical agents
0.006 0.994 0.000
Y56.7 Dental drugs, topically applied
0.006 0.994 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.006 0.994 0.000
Y56.5 Ophthalmological drugs and preparations
0.006 0.994 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.006 0.994 0.000
Y56.3 Emollients, demulcents and protectants
0.006 0.994 0.000
Y56.2 Local astringents and local detergents
0.006 0.994 0.000
Y56.1 Antipruritics
0.006 0.994 0.000
F10.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F10.8 Other mental and behavioural disorders
0.006 0.994 0.000
F10.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F10.6 Amnesic syndrome
0.006 0.994 0.000
F38 Other mood [affective] disorders
0.006 0.994 0.000
F39 Unspecified mood [affective] disorder
0.006 0.994 0.000
F43 Reaction to severe stress, and adjustment disorders
0.006 0.994 0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.006 0.994 0.000
F51 Nonorganic sleep disorders
0.006 0.994 0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.006 0.994 0.000
F55 Abuse of non-dependence-producing substances
0.006 0.994 0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.006 0.994 0.000
F30 Manic episode
0.006 0.994 0.000
Y46.8 Antispasticity drugs
0.006 0.994 0.000
Y46.7 Anti-Parkinsonism drugs
0.006 0.994 0.000
Y46.6 Other and unspecified antiepileptics
0.006 0.994 0.000
Y46.5 Valproic acid
0.006 0.994 0.000
Y46.4 Iminostilbenes
0.006 0.994 0.000
Y46.3 Deoxybarbiturates
0.006 0.994 0.000
Y46.2 Hydantoin derivatives
0.006 0.994 0.000
Y46.1 Oxazolidinediones
0.006 0.994 0.000
Y46.0 Succinimides
0.006 0.994 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.006 0.994 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.006 0.994 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.006 0.994 0.000
Y47.4 Bromine compounds
0.006 0.994 0.000
Y47.3 Paraldehyde
0.006 0.994 0.000
Y47.2 Chloral derivatives
0.006 0.994 0.000
Y47.1 Benzodiazepines
0.006 0.994 0.000
Y47.0 Barbiturates, not elsewhere classified
0.006 0.994 0.000
Y48.5 Therapeutic gases
0.006 0.994 0.000
Y48.4 Anaesthetic, unspecified
0.006 0.994 0.000
Y48.3 Local anaesthetics
0.006 0.994 0.000
Y48.2 Other and unspecified general anaesthetics
0.006 0.994 0.000
Y48.1 Parenteral anaesthetics
0.006 0.994 0.000
Y48.0 Inhaled anaesthetics
0.006 0.994 0.000
Y50.9 Central nervous system stimulant, unspecified
0.006 0.994 0.000
Y50.8 Other central nervous system stimulants
0.006 0.994 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.006 0.994 0.000
Y50.1 Opioid receptor antagonists
0.006 0.994 0.000
Y50.0 Analeptics
0.006 0.994 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.006 0.994 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.006 0.994 0.000
Y55.5 Anticommon cold drugs
0.006 0.994 0.000
Y55.4 Expectorants
0.006 0.994 0.000
Y55.3 Antitussives
0.006 0.994 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.006 0.994 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.006 0.994 0.000
Y55.0 Oxytocic drugs
0.006 0.994 0.000
Y58.9 Other and unspecified bacterial vaccines
0.006 0.994 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.006 0.994 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.006 0.994 0.000
Y58.5 Diphtheria vaccine
0.006 0.994 0.000
Y58.4 Tetanus vaccine
0.006 0.994 0.000
Y58.3 Plague vaccine
0.006 0.994 0.000
Y58.2 Cholera vaccine
0.006 0.994 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.006 0.994 0.000
Y58.0 BCG vaccine
0.006 0.994 0.000
Y59.9 Vaccine or biological substance, unspecified
0.006 0.994 0.000
Y59.8 Other specified vaccines and biological substances
0.006 0.994 0.000
Y59.3 Immunoglobulin
0.006 0.994 0.000
Y59.2 Protozoal vaccines
0.006 0.994 0.000
Y59.1 Rickettsial vaccines
0.006 0.994 0.000
Y59.0 Viral vaccines
0.006 0.994 0.000
Y40 Systemic antibiotics
0.006 0.994 0.000
F05.0 Delirium not superimposed on dementia, so described
0.006 0.994 0.000
Y49.9 Psychotropic drug, unspecified
0.006 0.994 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
Y49.7 Psychostimulants with abuse potential
0.006 0.994 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.006 0.994 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.006 0.994 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.006 0.994 0.000
Y49.2 Other and unspecified antidepressants
0.006 0.994 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.006 0.994 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.006 0.994 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.006 0.994 0.000
Y49.5 Other antipsychotics and neuroleptics
0.006 0.994 0.000
K02.8 Other dental caries
0.000 0.994 0.006
K02.5 Caries with pulp exposure
0.000 0.994 0.006
K02.4 Odontoclasia
0.000 0.994 0.006
K02.3 Arrested dental caries
0.000 0.994 0.006
K02.2 Caries of cementum
0.000 0.994 0.006
K02.1 Caries of dentin
0.000 0.994 0.006
K02.0 Caries limited to enamel
0.000 0.994 0.006
F12 Mental and behavioural disorders due to use of cannabinoids
0.005 0.994 0.000
Y54.9 Mineral salts, not elsewhere classified
0.005 0.994 0.000
Y54.8 Agents affecting uric acid metabolism
0.005 0.994 0.000
Y54.7 Agents affecting calcification
0.005 0.994 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.005 0.994 0.000
Y54.5 Other diuretics
0.005 0.994 0.000
Y54.4 Loop [high-ceiling] diuretics
0.005 0.994 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.005 0.994 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.005 0.994 0.000
Y54.0 Mineralocorticoids
0.005 0.994 0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type
0.005 0.994 0.000
F00.1 Dementia in Alzheimer's disease with late onset
0.005 0.994 0.000
F00.0 Dementia in Alzheimer's disease with early onset
0.005 0.994 0.000
Y52 Agents primarily affecting the cardiovascular system
0.005 0.994 0.000
F05.9 Delirium, unspecified
0.005 0.994 0.000
F52.2 Failure of genital response
0.005 0.994 0.000
F50.8 Other eating disorders
0.005 0.995 0.000
F50.5 Vomiting associated with other psychological disturbances
0.005 0.995 0.000
F50.4 Overeating associated with other psychological disturbances
0.005 0.995 0.000
F50.3 Atypical bulimia nervosa
0.005 0.995 0.000
F50.2 Bulimia nervosa
0.005 0.995 0.000
F50.1 Atypical anorexia nervosa
0.005 0.995 0.000
Y42.9 Other and unspecified hormone antagonists
0.005 0.995 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.005 0.995 0.000
Y42.4 Oral contraceptives
0.005 0.995 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
Y42.2 Antithyroid drugs
0.005 0.995 0.000
Y42.1 Thyroid hormones and substitutes
0.005 0.995 0.000
F06.7 Mild cognitive disorder
0.005 0.995 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.005 0.995 0.000
Y42.7 Androgens and anabolic congeners
0.005 0.995 0.000
Y54.3 Benzothiadiazine derivatives
0.005 0.995 0.000
F43.2 Adjustment disorders
0.005 0.995 0.000
F10.4 Withdrawal state with delirium
0.005 0.995 0.000
F19.9 Unspecified mental and behavioural disorder
0.005 0.995 0.000
F19.8 Other mental and behavioural disorders
0.005 0.995 0.000
F19.7 Residual and late-onset psychotic disorder
0.005 0.995 0.000
F19.6 Amnesic syndrome
0.005 0.995 0.000
F19.5 Psychotic disorder
0.005 0.995 0.000
F19.4 Withdrawal state with delirium
0.005 0.995 0.000
F19.3 Withdrawal state
0.005 0.995 0.000
F19.2 Dependence syndrome
0.005 0.995 0.000
F19.0 Acute intoxication
0.005 0.995 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.005 0.995 0.000
F05.8 Other delirium
0.005 0.995 0.000
F05.1 Delirium superimposed on dementia
0.005 0.995 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.995 0.000
F84 Pervasive developmental disorders
0.005 0.995 0.000
F11.2 Dependence syndrome
0.005 0.995 0.000
D50.1 Sideropenic dysphagia
0.005 0.995 0.000
F17.2 Dependence syndrome
0.005 0.995 0.000
G56.2 Lesion of ulnar nerve
0.000 0.995 0.005
F34.9 Persistent mood [affective] disorder, unspecified
0.005 0.995 0.000
F34.8 Other persistent mood [affective] disorders
0.005 0.995 0.000
F34.0 Cyclothymia
0.005 0.995 0.000
Y42.5 Other oestrogens and progestogens
0.005 0.995 0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease
0.005 0.995 0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease
0.005 0.995 0.000
F06.6 Organic emotionally labile [asthenic] disorder
0.005 0.995 0.000
F06.5 Organic dissociative disorder
0.005 0.995 0.000
F06.4 Organic anxiety disorder
0.005 0.995 0.000
F06.3 Organic mood [affective] disorders
0.005 0.995 0.000
F06.2 Organic delusional [schizophrenia-like] disorder
0.005 0.995 0.000
F06.1 Organic catatonic disorder
0.005 0.995 0.000
F06.0 Organic hallucinosis
0.005 0.995 0.000
F31 Bipolar affective disorder
0.005 0.995 0.000
F43.0 Acute stress reaction
0.005 0.995 0.000
F43.9 Reaction to severe stress, unspecified
0.005 0.995 0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease
0.005 0.995 0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease
0.005 0.995 0.000
F52.7 Excessive sexual drive
0.005 0.995 0.000
F52.6 Nonorganic dyspareunia
0.005 0.995 0.000
F52.5 Nonorganic vaginismus
0.005 0.995 0.000
F52.4 Premature ejaculation
0.005 0.995 0.000
F52.3 Orgasmic dysfunction
0.005 0.995 0.000
F52.1 Sexual aversion and lack of sexual enjoyment
0.005 0.995 0.000
F52.0 Lack or loss of sexual desire
0.005 0.995 0.000
F48 Other neurotic disorders
0.005 0.995 0.000
F44 Dissociative [conversion] disorders
0.005 0.995 0.000
F42 Obsessive-compulsive disorder
0.005 0.995 0.000
F89 Unspecified disorder of psychological development
0.005 0.995 0.000
F88 Other disorders of psychological development
0.005 0.995 0.000
F83 Mixed specific developmental disorders
0.005 0.995 0.000
F82 Specific developmental disorder of motor function
0.005 0.995 0.000
F11.9 Unspecified mental and behavioural disorder
0.005 0.995 0.000
F11.8 Other mental and behavioural disorders
0.005 0.995 0.000
F11.7 Residual and late-onset psychotic disorder
0.005 0.995 0.000
F11.6 Amnesic syndrome
0.005 0.995 0.000
F11.5 Psychotic disorder
0.005 0.995 0.000
F11.4 Withdrawal state with delirium
0.005 0.995 0.000
F11.3 Withdrawal state
0.005 0.995 0.000
F11.1 Harmful use
0.005 0.995 0.000
F11.0 Acute intoxication
0.005 0.995 0.000
F60 Specific personality disorders
0.005 0.995 0.000
F81 Specific developmental disorders of scholastic skills
0.005 0.995 0.000
F45 Somatoform disorders
0.005 0.995 0.000
F80 Specific developmental disorders of speech and language
0.005 0.995 0.000
F02.8 Dementia in other specified diseases classified elsewhere
0.005 0.995 0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease
0.005 0.995 0.000
F02.3 Dementia in Parkinson's disease
0.005 0.995 0.000
F02.2 Dementia in Huntington's disease
0.005 0.995 0.000
F02.1 Dementia in Creutzfeldt-Jakob disease
0.005 0.995 0.000
F02.0 Dementia in Pick's disease
0.005 0.995 0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
0.005 0.995 0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
0.005 0.995 0.000
F07.2 Postconcussional syndrome
0.005 0.995 0.000
F07.1 Postencephalitic syndrome
0.005 0.995 0.000
F07.0 Organic personality disorder
0.005 0.995 0.000
F68 Other disorders of adult personality and behaviour
0.005 0.995 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.005 0.995 0.000
F65 Disorders of sexual preference
0.005 0.995 0.000
F64 Gender identity disorders
0.005 0.995 0.000
F63 Habit and impulse disorders
0.005 0.995 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.005 0.995 0.000
F69 Unspecified disorder of adult personality and behaviour
0.005 0.995 0.000
F61 Mixed and other personality disorders
0.005 0.995 0.000
F01.8 Other vascular dementia
0.005 0.995 0.000
F01.3 Mixed cortical and subcortical vascular dementia
0.005 0.995 0.000
F01.2 Subcortical vascular dementia
0.005 0.995 0.000
F01.1 Multi-infarct dementia
0.005 0.995 0.000
F01.0 Vascular dementia of acute onset
0.005 0.995 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.005 0.995 0.000
F79 Unspecified mental retardation
0.004 0.995 0.000
F78 Other mental retardation
0.004 0.995 0.000
F73 Profound mental retardation
0.004 0.995 0.000
F72 Severe mental retardation
0.004 0.995 0.000
F71 Moderate mental retardation
0.004 0.995 0.000
F70 Mild mental retardation
0.004 0.995 0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.004 0.995 0.000
F95 Tic disorders
0.004 0.995 0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.004 0.995 0.000
F93 Emotional disorders with onset specific to childhood
0.004 0.995 0.000
F92 Mixed disorders of conduct and emotions
0.004 0.995 0.000
F91 Conduct disorders
0.004 0.995 0.000
F90 Hyperkinetic disorders
0.004 0.995 0.000
F01.9 Vascular dementia, unspecified
0.005 0.995 0.000
F13.9 Unspecified mental and behavioural disorder
0.004 0.995 0.000
F13.8 Other mental and behavioural disorders
0.004 0.995 0.000
F13.7 Residual and late-onset psychotic disorder
0.004 0.995 0.000
F13.6 Amnesic syndrome
0.004 0.995 0.000
F13.5 Psychotic disorder
0.004 0.995 0.000
F13.4 Withdrawal state with delirium
0.004 0.995 0.000
F13.3 Withdrawal state
0.004 0.995 0.000
F13.2 Dependence syndrome
0.004 0.995 0.000
F13.1 Harmful use
0.004 0.995 0.000
F13.0 Acute intoxication
0.004 0.995 0.000
F14.9 Unspecified mental and behavioural disorder
0.004 0.995 0.000
F14.8 Other mental and behavioural disorders
0.004 0.995 0.000
F14.7 Residual and late-onset psychotic disorder
0.004 0.995 0.000
F14.6 Amnesic syndrome
0.004 0.995 0.000
F14.5 Psychotic disorder
0.004 0.995 0.000
F14.4 Withdrawal state with delirium
0.004 0.995 0.000
F14.3 Withdrawal state
0.004 0.995 0.000
F14.2 Dependence syndrome
0.004 0.995 0.000
F14.1 Harmful use
0.004 0.995 0.000
F14.0 Acute intoxication
0.004 0.995 0.000
F15.9 Unspecified mental and behavioural disorder
0.004 0.995 0.000
F15.8 Other mental and behavioural disorders
0.004 0.995 0.000
F15.7 Residual and late-onset psychotic disorder
0.004 0.995 0.000
F15.6 Amnesic syndrome
0.004 0.995 0.000
F15.5 Psychotic disorder
0.004 0.995 0.000
F15.4 Withdrawal state with delirium
0.004 0.995 0.000
F15.3 Withdrawal state
0.004 0.995 0.000
F15.2 Dependence syndrome
0.004 0.995 0.000
F15.1 Harmful use
0.004 0.995 0.000
F15.0 Acute intoxication
0.004 0.995 0.000
F16.9 Unspecified mental and behavioural disorder
0.004 0.995 0.000
F16.8 Other mental and behavioural disorders
0.004 0.995 0.000
F16.7 Residual and late-onset psychotic disorder
0.004 0.995 0.000
F16.6 Amnesic syndrome
0.004 0.995 0.000
F16.5 Psychotic disorder
0.004 0.995 0.000
F16.4 Withdrawal state with delirium
0.004 0.995 0.000
F16.3 Withdrawal state
0.004 0.995 0.000
F16.2 Dependence syndrome
0.004 0.995 0.000
F16.1 Harmful use
0.004 0.995 0.000
F16.0 Acute intoxication
0.004 0.995 0.000
F18.9 Unspecified mental and behavioural disorder
0.004 0.995 0.000
F18.8 Other mental and behavioural disorders
0.004 0.995 0.000
F18.7 Residual and late-onset psychotic disorder
0.004 0.995 0.000
F18.6 Amnesic syndrome
0.004 0.995 0.000
F18.5 Psychotic disorder
0.004 0.995 0.000
F18.4 Withdrawal state with delirium
0.004 0.995 0.000
F18.3 Withdrawal state
0.004 0.995 0.000
F18.2 Dependence syndrome
0.004 0.995 0.000
F18.1 Harmful use
0.004 0.995 0.000
F18.0 Acute intoxication
0.004 0.995 0.000
F30.0 Hypomania
0.004 0.995 0.000
F38.8 Other specified mood [affective] disorders
0.004 0.995 0.000
F38.1 Other recurrent mood [affective] disorders
0.004 0.995 0.000
F38.0 Other single mood [affective] disorders
0.004 0.995 0.000
F43.8 Other reactions to severe stress
0.004 0.995 0.000
F30.8 Other manic episodes
0.004 0.996 0.000
F30.2 Mania with psychotic symptoms
0.004 0.996 0.000
F30.1 Mania without psychotic symptoms
0.004 0.996 0.000
F51.9 Nonorganic sleep disorder, unspecified
0.004 0.996 0.000
F51.8 Other nonorganic sleep disorders
0.004 0.996 0.000
F51.5 Nightmares
0.004 0.996 0.000
F51.4 Sleep terrors [night terrors]
0.004 0.996 0.000
F51.3 Sleepwalking [somnambulism]
0.004 0.996 0.000
F51.2 Nonorganic disorder of the sleep-wake schedule
0.004 0.996 0.000
F51.1 Nonorganic hypersomnia
0.004 0.996 0.000
F51.0 Nonorganic insomnia
0.004 0.996 0.000
F53.9 Puerperal mental disorder, unspecified
0.004 0.996 0.000
F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.004 0.996 0.000
F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.004 0.996 0.000
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.004 0.996 0.000
Y40.7 Antifungal antibiotics, systemically used
0.004 0.996 0.000
Y40.6 Rifamycins
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.004 0.996 0.000
Y40.4 Tetracyclines
0.004 0.996 0.000
Y40.2 Chloramphenicol group
0.004 0.996 0.000
Y40.3 Macrolides
0.004 0.996 0.000
F41 Other anxiety disorders
0.004 0.996 0.000
L73.2 Hidradenitis suppurativa
0.004 0.996 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.004 0.996 0.000
F30.9 Manic episode, unspecified
0.004 0.996 0.000
Y43 Primarily systemic agents
0.004 0.996 0.000
F12.9 Unspecified mental and behavioural disorder
0.004 0.996 0.000
F12.8 Other mental and behavioural disorders
0.004 0.996 0.000
F12.7 Residual and late-onset psychotic disorder
0.004 0.996 0.000
F12.6 Amnesic syndrome
0.004 0.996 0.000
F12.5 Psychotic disorder
0.004 0.996 0.000
F12.4 Withdrawal state with delirium
0.004 0.996 0.000
F12.3 Withdrawal state
0.004 0.996 0.000
F12.2 Dependence syndrome
0.004 0.996 0.000
F12.0 Acute intoxication
0.004 0.996 0.000
F84.5 Asperger's syndrome
0.004 0.996 0.000
F99 Mental disorder, not otherwise specified
0.004 0.996 0.000
F10.2 Dependence syndrome
0.004 0.996 0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
0.004 0.996 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.004 0.996 0.000
Chapter XX External causes of morbidity and mortality
0.004 0.996 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.004 0.996 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.996 0.000
Y52.7 Peripheral vasodilators
0.004 0.996 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.004 0.996 0.000
Y52.1 Calcium-channel blockers
0.004 0.996 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.004 0.996 0.000
F32 Depressive episode
0.004 0.996 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.004 0.996 0.000
F17.9 Unspecified mental and behavioural disorder
0.004 0.996 0.000
F17.8 Other mental and behavioural disorders
0.004 0.996 0.000
F17.7 Residual and late-onset psychotic disorder
0.004 0.996 0.000
F17.6 Amnesic syndrome
0.004 0.996 0.000
F17.5 Psychotic disorder
0.004 0.996 0.000
F17.4 Withdrawal state with delirium
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.